Professional Summary

Professional Overview

Nadia Agopyan is a seasoned pharmaceutical executive with over 30 years of experience in the biopharmaceutical industry. As the Senior Vice President at Neurona Therapeutics, she leverages her deep expertise in regulatory affairs and global market access to drive the company's strategic initiatives and support the development and commercialization of its innovative therapeutic solutions.

Experience Summary

Current Role

In her current role as Senior VP at Neurona Therapeutics, Nadia is responsible for overseeing the company's regulatory strategy and leading cross-functional teams to navigate the complex regulatory landscape. She works closely with global regulatory authorities to ensure the timely and successful advancement of Neurona's pipeline, contributing to the organization's overall growth and market impact.

Career Progression

Prior to joining Neurona Therapeutics, Nadia held senior leadership positions at several prominent biopharmaceutical companies. As the Senior Vice President and Head of Regulatory Affairs at Marker Therapeutics, Inc., she played a pivotal role in shaping the company's global regulatory strategy, supporting the development of its novel immunotherapies. Earlier in her career, Nadia served as the Global Regulatory Affairs Lead at Kite Pharma, Inc. and Baxter Bioscience, where she demonstrated her ability to navigate complex regulatory environments and drive the successful market authorization of cutting-edge therapies.

Academic Background

Nadia holds a Ph.D. in Molecular Biology from the University of Toronto, where she conducted groundbreaking research and published numerous peer-reviewed articles. Her academic achievements and deep scientific expertise have been instrumental in her ability to navigate the intricate regulatory landscape and provide strategic guidance to her teams.

Areas of Expertise

• Regulatory affairs and market access strategy

• Global regulatory compliance and submissions

• Clinical development and trial design

• Biopharmaceutical product commercialization

• Cross-functional team leadership and collaboration

• Navigating complex regulatory environments

Professional Impact

Throughout her distinguished career, Nadia has made significant contributions to the biopharmaceutical industry. She has played a pivotal role in the successful regulatory approval and market launch of several innovative therapies, making a tangible impact on patients' lives. Her expertise and strategic leadership have been instrumental in driving the growth and success of the organizations she has been a part of.

Conclusion

Nadia Agopyan's extensive experience, exceptional regulatory expertise, and proven track record of success make her a valuable asset to Neurona Therapeutics. As the Senior Vice President, she is poised to continue driving the company's strategic initiatives, fostering innovation, and contributing to the development and commercialization of transformative therapeutic solutions.